Dynamic value assessments in oncology supported by the PACE Continuous Innovation Indicators.

about

Dynamic value assessments in oncology supported by the PACE Continuous Innovation Indicators.

Item

http://www.wikidata.org/entity/Q38651603

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Dynamic value assessments in o ...... tinuous Innovation Indicators.

@en

type

Item

label

Dynamic value assessments in o ...... tinuous Innovation Indicators.

@en

prefLabel

Dynamic value assessments in o ...... tinuous Innovation Indicators.

@en

P1476

Dynamic value assessments in o ...... tinuous Innovation Indicators.

@en

P2093

Clifford Goodman

http://www.w3.org/2001/XMLSchema#string

David Grainger

http://www.w3.org/2001/XMLSchema#string

Jacqueline Zummo

http://www.w3.org/2001/XMLSchema#string

Samuel Thomas

http://www.w3.org/2001/XMLSchema#string

Scott Shortenhaus

http://www.w3.org/2001/XMLSchema#string

Silvia Paddock

http://www.w3.org/2001/XMLSchema#string

P2860

PACE Continuous Innovation Indicators-a novel tool to measure progress in cancer treatments.

The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization.

From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.

The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer.

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response

P31

scholarly article

P356

10.2217/FON-2017-0241

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28745521

http://www.w3.org/2001/XMLSchema#string